Michael Doherty, Head of Department and Director of Clinical & Epidemiological Research, Faculty of Medicine and Health Sciences, University of Nottingham, UK, Hans Bijlsma, Professor of Rheumatology, University of Amsterdam and Free University at Amsterdam, The Netherlands, Nigel Arden, Professor in Rheumatic Diseases, Director of Musculoskeletal Epidemiology and Biobank, University of Oxford, UK, David Hunter, Florance and Cope Chair of Rheumatology Medicine, Royal North Shore Hospital, The University of Sydney, Australia, and Nicola Dalbeth, Associate Professor, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
Professor Michael Doherty MA MD FRCP FHEA is Professor of Rheumatology and Head of Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham. His main research interests are osteoarthritis (OA), gout, calcium pyrophosphate crystal deposition (CPPD), placebo/contextual response and evidence based medicine. He has expertise in clinical and epidemiological studies, community-based clinical trials, systematic reviews and meta-analyses. He has over 300 original research publications and was awarded the OA Research Society International (OARSI) Clinical Research Award for 2012. He is a past editor of Annals of the Rheumatic Diseases (1992-99), has co-chaired EULAR Task Forces for recommendations for OA, gout and CPPD arthritis, and has been involved as a clinical expert in NICE appraisals for OA and gout.
Johannes (Hans) Bijlsma is professor of Rheumatology at the University of Utrecht, as well as at both Universities (VU and UVA) in Amsterdam. He was Head of the Department of Rheumatology and Immunology in Utrecht (1989-2013) and of the Amsterdam Rheumatology and immunology Center (2013-2015). His main research interests are osteoarthritis (OA), treatment strategies in rheumatoid arthritis and glucocorticoids. He has expertise in clinical and epidemiological studies, randomised controlled clinical trials in early RA, systematic reviews and meta-analyses. He has over 600 original research publications and was awarded the Jan van Breemen Award for his scientific work in the Netherlands (2015). He is an associate editor of Annals of the Rheumatic Diseases (2005 - ongoing), has co-chaired EULAR Task Forces for recommendations for OA and the use of glucocorticoids. He has been the chair of Education of EULAR, the coordinator of the EULAR online courses and is presently the President-elect of EULAR
Nigel Arden is a Professor of Rheumatic Diseases and an International Leader in Epidemiology and predictive modelling and trial design. He has clinical and research expertise in osteoarthritis, arthroplasty and osteoporosis and has published numerous manuscripts based on the use of cohort and large routinely collected databases in musculoskeletal diseases and their treatment. His research interests focus on the epidemiology of musculoskeletal diseases, with a focus on Osteoarthritis and Osteoporosis. He is based in the Botnar Research Centre, University of Oxford with additional sessions at the MRC Lifecourse Epidemiology Unit at the University of Southampton.
Professor David Hunter is a rheumatology clinician researcher whose main research focus has been clinical and translational research in osteoarthritis (OA). He is the Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney, and Staff Specialist at Royal North Shore Hospital and North Sydney Orthopaedic and Sports Medicine Centre. His research is focused on a number of key elements in OA including (but not limited to) the epidemiology of osteoarthritis, the application of imaging to better understand structure and function with application to both epidemiologic research and clinical trials, novel therapies in disease management and heath service system delivery of chronic disease management. He is an editor for leading international journals in his field. He has authored books on osteoarthritis and has over 350 publications in peer reviewed journals.
Professor Nicola Dalbeth is an academic rheumatologist who leads a clinical and laboratory programme of research in gout, an inflammatory arthritis of major significance to Aotearoa New Zealand. Her work focuses on understanding the impact and mechanisms of disease in gout. She is a founding member of the Counties Manukau District Health Board Maori Gout Action Group, and she was the Lead Clinical Advisor for the Gout Clinical Pathways (Greater Auckland Integrated Healthcare Network) and the national bpac Gout Treatment Guidelines. She has served as an Expert Panel member on the American College of Rheumatology Gout Management Guidelines, and is a steering committee member for the OMERACT gout working group and the ACR/EULAR gout classification project.
Contributors:
Abhishek Abhishek- Nottingham City Hospital, UK
Adrian Jones - Nottingham City Hospital, UK
Ali Guermazi - Boston University School of Medicine, USA
Allen D Sawitzke- University of Utah, USA
Ana M Valdes- City Hospital Nottingham, The University of Nottingham, UK
Andrew Price- University of Oxford, Nuffield Orthopaedic Centre, Oxford, UK
Anne Lyddiatt- Cochrane Collaboration Musculoskeletal Review Group, Ottawa, Canada
Ans Van Ginckel- The University of Melbourne, Australia
Berit L. Heitmann- Copenhagen University Hospital Bispebjerg-Frederiksberg, Denmark
Bernard Bannwarth- Groupe Hospitalier Pellegrin and Division of Therapeutics, Université Victor Segalen, Bordeaux, France.
Caroline A Brand- Centre for Research Excellence in Patient Safety, Monash University, Melbourne, Australia
Changhai Ding- Menzies Research Institute Tasmania, University of Tasmania/Institute of Bone & Joint Research, University of Sydney, Australia
Christelle Nguyen- Université Paris Diderot and INSERM, Hôpital Lariboisière, Paris, France
Cindy Veenhof- University Medical Center, Utrecht, The Netherlands
Daichi Hayashi- Boston University School of Medicine, USA
Daniel Bossen- Netherlands Institute for Health Services Research, Utrecht, the Netherlands
Daniel O Clegg- University of Utah, USA
David A Walsh- Arthritis Research UK Pain Centre, City Hospital Nottingham, UK
David Beard- University of Oxford, UK
Dawn Stacey- School of Nursing, University of Ottawa, Ottawa, Ontario, Canada
Edward Roddy- Arthritis Research UK, Keele University, UK
Eliseo Pascual- Hospital General Universitario de Alicante, Spain
Emilio Filippucci- Clinica Reumatologica, Università Politecnica delle Marche, Ancona, Italy
Esmeralda N Blaney Davidson- Radboud University Medical Centre, The Netherlands
Esther Waugh- University of Toronto, Canada
Fernando Perez-Ruiz- BioCruces Health Institute, Biskay, Spain
Fiona Dobson- University of Melbourne, Australia
Floris Lafeber- University Medical Centre Utrecht, The Netherlands
Francis Berenbaum- AP-HP Saint Antoine hospital, Pierre & Marie Curie University, Paris, France
Francisca Sivera- Hospital General Universitario de Alicante, Spain
François Rannou- Laboratoire de Pharmacologie, Toxicologie et Signalisation Moléculaire, Paris, France
Frank W. Roemer- Klinikum Augsburg, Augsburg, Germany
Gillian Hawker- University of Toronto, Women's College Hospital, Toronto, Canada
Henning Bliddal- Copenhagen University Hospital Bispebjerg-Frederiksberg, Denmark
Ilana N Ackerman- Melbourne EpiCentre, Department of Medicine (Royal Melbourne Hospital) The University of Melbourne, Australia
Irati Urionaguena - Rheumatology Division, Hospital Universitario Cruces, OSI EE-Cruces, Baracaldo, Spain
J. Runhaar- Erasmus MC University Medical Center, Rotterdam, The Netherlands
Jasmijn Holla- Amsterdam Rehabilitation Research Centre | Reade, Amsterdam, The Netherlands
Jason J. McDougall- McCaig Centre for Joint Injury and Arthritis Research, University of Calgary, Canada
Jenny Gregory- University of Aberdeen, UK
Joanne M. Jordan- Thurston Arthritis Research Center, University of North Carolina, USA
Joel A. Vilensky- Indiana University School of Medicine, USA
Jonas Bloch Thorlund- University of Southern Denmark, Denmark
Joost Dekker- VUMC, Amsterdam, The Netherlands
Juliet Rogers- University of East Anglia, Norwich, UK
Kelli D. Allen- Thurston Arthritis Research Center, University of North Carolina, USA
Kim L Bennell- University of Melbourne, Australia
KS Dziedzic- Arthritis Research UK, Keele University, UK
L. Stefan Lohmander- University of Southern Denmark, Denmark
Laura A. Stoppiello- Arthritis Research UK Pain Centre, University of Nottingham, UK
Lee S. Simon- SDG LLC, Cambridge, UK
Leigh F. Callahan- Thurston Arthritis Research Center, University of North Carolina, USA
Leticia Alle Deveza- Royal North Shore Hospital, The University of Sydney, Australia
Linda Li- The University of British Columbia, Vancouver, Canada
MA Holden- Arthritis Research UK, Keele University, UK
Marc C. Hochberg- University of Maryland School of Medicine, Baltimore, USA
Margreet Kloppenburg- Leiden University Medical Center, The Netherlands
Mariëtte de Rooij- Amsterdam Rehabilitation Research Centre | Reade, Amsterdam, The Netherlands
Marike van der Leeden- VU University Medical Centre, Amsterdam, The Netherlands
Marius Henriksen- Copenhagen University Hospital Bispebjerg-Frederiksberg, Denmark
Michael C. Nevitt- University of California, San Francisco, USA
MJ Thomas- Arthritis Research UK, Keele University, UK
N.J. Besselink- University Medical Centre Utrecht, The Netherlands
Naomi Schlesinger- Rutgers Robert Wood Johnson Medical School, New Jersey, USA
Pascal Richette- Fédération de rhumatologie, hôpital Lariboisière, Paris, France.
Paul Dieppe, University of Exeter, UK
Paul Monk- University of Oxford, UK
Peter M van der Kraan- Radboud University Medical Centre, The Netherlands
Philip Mease- University of Washington School of Medicine, Seattle, USA
Puja Khanna- University of Michigan, Kragujevac, USA
Rana S Hinman- University of Melbourne, Australia
Richard Aspden- University of Aberdeen, UK
Robert T. Keenan- Duke University School of Medicine, USA
Robin Christensen- Copenhagen University Hospital Bispebjerg-Frederiksberg, Denmark
S.C. Mastbergen- University Medical Centre Utrecht, The Netherlands
S.M.A. Bierma-Zeinstra- Erasmus MC University Medical Center, Rotterdam, The Netherlands
Samantha Hider- Kelle University, UK
Sandra P. Chinchilla- Hospital Universitario Cruces, Vizcaya, Spain
Sarah Munce- Toronto Rehabilitation Institute, Toronto, Canada
Shirley Pei-Chun Yu- University of Sydney, Sydney, Australia
Sneha Pai- Rutgers Robert Wood Johnson Medical School, New Jersey, USA
Steven R. Goldring- Hospital for Special Surgery, Cornell University, New York, USA
Susan Jaglal- University of Toronto, Canada
Tadashi Okano- Osaka City University Graduate School of Medicine, Osaka, Japan
Terence O'Neill- Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester
Thomas Bardin- Hôpital Lariboisière, Paris, France
Tim L Jansen- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Tony R Merriman- University of Otago, Dunedin, New Zealand
Walter Grassi- Università Politecnica delle Marche, Jesi, Ancona, Italy
Weiya Zhang- City Hospital, Nottingham, UK
Xia Wang- Menzies Research Institute Tasmania, University of Tasmania/Institute of Bone & Joint Research, University of Sydney, Australia
Xingzhong Jin- Menzies Research Institute Tasmania, University of Tasmania/Institute of Bone & Joint Research, University of Sydney, Australia
Zhaohua Zhu- First Affiliated Hospital of Anhui Medical University, Hefei, China and Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia
